Verily, Alphabet's life sciences subsidiary, recently made the tough decision to lay off staff and shut down its long-running devices program. This move, revealed in a memo from CEO Stephen Gillett, reflects the company's commitment to refining its focus.
The Evolution of Verily's Strategy
Transitioning Towards AI and Infrastructure
Originally a moonshot within Google's X lab, Verily has undergone significant changes to optimize its operations. The company is now prioritizing artificial intelligence (AI) development and creating infrastructure to support external businesses.
The End of an Era for Verily's Devices Program
Legacy of Innovative Medical Devices
Verily's decision to wind down its devices program marks the end of an era for its groundbreaking medical devices. The program, responsible for projects like a clinical study watch and a wearable glucose sensor in partnership with Dexcom, has been pivotal in advancing healthcare technology.
Strategic Business Refocus
Verily's spokesperson emphasized that the company's shift away from manufacturing medical devices aligns with its strategic refocus since 2023. By simplifying and streamlining operations, Verily aims to achieve sustained commercial success.
Verily's Path to Independence
Detachment from Alphabet's Umbrella
While still under Alphabet's ownership, Verily is gradually distancing itself from Google's technology and services. This move is part of Verily's larger goal of becoming a fully independent entity, as highlighted by company leaders.
Recent Business Changes
Verily's divestment of its insurance business earlier this year and adjustments to employee benefits and salary bands underscore the ongoing transformations within the company.
Stephen Gillett's Address to Verily Employees
Message of Appreciation and Confidence
In a heartfelt memo to Verily employees, Stephen Gillett expressed gratitude for departing team members' contributions and acknowledged the difficulty of the transition. He reassured remaining staff of Verily's unwavering commitment to its core mission in precision health, data, and AI.
As Verily navigates these challenging changes, the company's dedication to innovation and healthcare remains steadfast. By focusing on its core strengths and strategic objectives, Verily is poised to continue making a positive impact on human health.
—————————————————————————————————————————————
By: hlangley@businessinsider.com (Hugh Langley)
Title: Verily CEO Stephen Gillett Announces Staff Layoffs and Devices Program Cuts
Sourced From: www.businessinsider.com/alphabets-verily-lays-off-staff-cuts-its-devices-program-2025-8
Published Date: Tue, 26 Aug 2025 22:16:01 +0000
Leave a Reply